The U.S. Department of Health and Human Services' Office of Inspector General announced a temporary delay in the effective date of certain amendments to a rule about safe harbor protections for prescription drug rebates. This decision is in line with the "Regulatory Freeze Pending Review" memo from January 20, 2021, and is due to ongoing litigation challenging the rule. The effective date for these amendments, initially set for January 29, 2021, is postponed to March 22, 2021, to allow time for further review and consideration. Additionally, a correction was made to a technical error in the published amendatory instructions.
Simple Explanation
The government decided to hit the pause button on some new rules about how pharmacies and companies get special discounts on medicine because people are arguing about it in court, and they also found a tiny mistake they had to fix. They're hoping this short break will help everyone figure things out better.